Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status
Alexander Rühle, Enrique Sanz-Garcia, Jie Su, Brian O’Sullivan et autres
0 citationsRadiotherapy and Oncology
Lillian L. Siu
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
1306Publications signalées
42205Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies
Publications récentes
A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors
Lillian L. Siu, Omid Hamid, Reva Schneider, Jordi Rodón et autres
0 citationsClinical Cancer Research
EphA4 Mediates Pro- and Antitumoral Effects Through Upstream Negative Regulation of AKT in Head and Neck Squamous Cell Carcinoma
Sophia Corbo, Khalid N.M. Abdelazeem, Diemmy Nguyen, Shilpa Bhatia et autres
0 citationsCancer Immunology Research
Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer
Mercedes Herrera, Sajid A. Marhon, Zhihui Amy Liu, Helen Loo Yau et autres
0 citationsCancer Immunology Research
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer
Lucas Penny, Eric Yang Stutheit‐Zhao, Birgitta E. Michels, Fabian Rosing et autres
0 citationsInternational Journal of Cancer
Supplementary Table 6 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J. Elliott, Karen Howarth, Sasha Main, Jesús Fuentes‐Antrás et autres
0 citations
Supplementary Table S2 from AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
Lillian L. Siu, Sophie Postel‐Vinay, Rafael Villanueva-Vázquez, Guillermo de Velasco et autres
0 citations
Supplementary Figure 1 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J. Elliott, Karen Howarth, Sasha Main, Jesús Fuentes‐Antrás et autres
0 citations
Supplementary Figure 2 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J. Elliott, Karen Howarth, Sasha Main, Jesús Fuentes‐Antrás et autres
0 citations
Supplementary Figure 4 from Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J. Elliott, Karen Howarth, Sasha Main, Jesús Fuentes‐Antrás et autres
0 citations
Supplementary Table S11 from AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
Lillian L. Siu, Sophie Postel‐Vinay, Rafael Villanueva-Vázquez, Guillermo de Velasco et autres
0 citations
Supplementary Table S1 from AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
Lillian L. Siu, Sophie Postel‐Vinay, Rafael Villanueva-Vázquez, Guillermo de Velasco et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.